Clinicians and laboratory professionals can rely on molar unit measurements to know the Lp(a) particle numbers.

Cardiologists reveal the unexpected symptoms of clogged arteries and underlying heart disease that you should know about. The ...

NEW equations, named AROSE, have been developed to better predict the 10-year risk of atherosclerotic cardiovascular disease ...

About Verve Therapeutics Verve Therapeutics, Inc. (Nasdaq: VERV) is a clinical-stage company developing a new class of genetic medicines for cardiovascular disease with the potential to transform ...

Among older adults and adults with low ASCVD risk for whom aspirin is not recommended, use of aspirin decreased after 2019 ...

Many historically underrepresented groups, individuals on Medicaid and some without insurance at low atherosclerotic risk continue to take low-dose aspirin despite bleeding risk, in contrast to recent ...

Cutaneous lupus erythematosus (CLE) is associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD).

A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target ...

After guideline changes, aspirin use dropped off overall, even for higher-risk patients in whom it might still be considered.

A research team led by Prof. WENG Jianping from the University of Science and Technology of China (USTC) of the Chinese ...

Individuals with cutaneous lupus erythematosus have an increased ASCVD risk when compared with those without cutaneous lupus erythematosus.

Following landmark clinical trials and changes in guideline recommendations, self-reported primary prevention aspirin use decreased among older adults and adults with low ...